Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 11.627\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. Cn1c(Cc2cccs2)nnc1SCC(=O)Nc1ccccc1
b. COc1ccc(CN2C(=O)CCC2(C)C(=O)NCc2cccnc2)c(OC)c1
c. O=C(O)c1ccccc1CSc1nc2ccccc2[nH]1
d. CCSc1nnc(NC(=O)c2ccco2)s1
Answer: a. Cn1c(Cc2cccs2)nnc1SCC(=O)Nc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(Cc2cccs2)nnc1SCC(=O)Nc1ccccc1
Cn1c(Cc2cccs2)nnc1SCC(=O)Nc1ccccc1
2-[[4-methyl-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-phenylacetamide